Table: SevenSeas Holdings -2017/18 group results

ADR Biomedical Holdings

10/05/2018 07:00

May 10 (Reuters)- 
          SevenSeas Holdings Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          522 mln          2.69           3.00                  
               (-80.6 pct)     (+0.3 pct)    (+474.5 pct)              
  Operating      130 mln      loss 398 mln      430 mln                
                                             (+229.6 pct)              
  Recurring      127 mln      loss 397 mln      400 mln                
                                             (+213.6 pct)              
  Net                                           400 mln                
                                              (-11.1 pct)              
  Net            449 mln      loss 464 mln                             
  EPS           66.25 yen    loss 65.81 yen    58.90 yen               
  Ann Div       10.00 yen          NIL         10.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       10.00 yen          NIL         10.00 yen               
  
  NOTE - SevenSeas Holdings Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T